Fidelity D&D Bancorp’s AbbVie ABBV Stock Holding History

Fidelity D&D Bancorp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$573K	Buy	2,278 +160	+8%	+$34.4K	0.2%	51
2026 Q1	$461K	Buy	2,118 +68	+3%	+$15.1K	0.18%	54
2025 Q4	$468K	Sell	2,050 -106	-5%	-$24.1K	0.2%	55
2025 Q3	$499K	Sell	2,156 -50	-2%	-$10.2K	0.28%	50
2025 Q2	$409K	Sell	2,206 -1,005	-31%	-$187K	0.25%	52
2025 Q1	$673K	Hold	3,211	–	–	0.44%	44
2024 Q4	$571K	Buy	3,211 +212	+7%	+$39K	0.38%	46
2024 Q3	$592K	Sell	2,999 -382	-11%	-$71.3K	0.39%	45
2024 Q2	$580K	Sell	3,381 -45	-1%	-$7.45K	0.44%	41
2024 Q1	$624K	Buy	3,426 +74	+2%	+$12.8K	0.47%	39
2023 Q4	$519K	Sell	3,352 -162	-5%	-$23.6K	0.4%	44
2023 Q3	$524K	Buy	+3,514	New	+$516K	0.54%	38
2023 Q1	$624K	Buy	+3,426	New	+$524K	0.47%	39

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity D&D Bancorp's ABBV Position: Q2 2026 in Review

Fidelity D&D Bancorp increased its AbbVie (ABBV) stake by 7.6% in Q2 2026, buying an estimated $34.4K and bringing the position to 2,278 shares worth $573K. The position accounts for 0.2% of the portfolio, ranked #51.

Fidelity D&D Bancorp first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. The position peaked at $673K in Q1 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Fidelity D&D Bancorp held 2,278 shares of AbbVie worth $573K as of Q2 2026.
Fidelity D&D Bancorp bought 160 AbbVie shares in Q2 2026, an estimated $34.4K.
AbbVie made up 0.2% of Fidelity D&D Bancorp's portfolio in Q2 2026, its #51 holding.
Fidelity D&D Bancorp first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
Fidelity D&D Bancorp's AbbVie position peaked at $673K in Q1 2025.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fidelity D&D Bancorp's 13F filing for Q2 2026, filed 6 Aug 2026.